When updated food allergy prevention guidelines were directly provided to families, they led to earlier allergen introduction ...

Factors such as age, smoking status, and body mass index can help clinicians predict a patient’s risk of 30-day mortality.

Following the FDA approval of linvoseltamab (Lynozyfic; Regeneron) for heavily pretreated multiple myeloma, Sundar Jagannath, MBBS, highlights its potential for earlier use, increased accessibility, ...

Quality of life in people living with HIV was lower in those who had weight gain from adherence to antiretroviral therapy.

A recent study suggests hemorrhagic events following essential thrombocythemia diagnosis are among the most significant ...

Investigators found certain classes of prescriptions were also associated with outcomes, though they do not believe the ...

Nurses enhance chronic kidney disease (CKD) care by implementing a palliative CKD care framework, addressing barriers, and ...

Noting the profound impact of living with a chronic condition that constantly reminds patients of their "patient" status, ...

Quantitative muscle ultrasound correlates strongly with ambulatory and timed function tests in Duchenne muscular dystrophy, ...

Improving health literacy is essential for promoting health equity, reducing preventable illness, and making health care more ...

Tov, MD, advocates for a holistic approach to wound care, emphasizing that chronic ulcers often signal underlying systemic health issues requiring a comprehensive patient assessment to achieve ...

The newly FDA-approved linvoseltamab (Lynozyfic; Regeneron) may improve access to multiple myeloma treatment by offering an off-the-shelf, outpatient option that can be administered in community ...